GFN 2015

gfn2016-17-18-JUNE-with-strapline

 

 

 

 

The videos below are from the second Global Forum on Nicotine, held again in Warsaw, Poland, on June 5 & 6 2015. The event was organized by Knowledge Action Change. More from the conference – including pdfs of presentations, posters and photos – can be found on the conference archive at http://gfn.net.co/. Special thanks to Jon Derricott for his work filming the event.

For details about next year’s Global Forum, taking place in Warsaw on 17 &18 June 2016, please visit http://gfn.net.co/2016. The theme for the conference will be ‘Evidence, Accountability, Transparency’

Keynote Address: “Michael Russell Oration” – Introduced by Dr. Delon Human

Presented by Dr. Derek Yach

Presented by Dr. Derek Yach

Dr. Yach is interviewed at GFN after the keynote address oration
Watch Video
“Derek Yach has focused his career on advancing global health and tackling tobacco control at national and international levels. He leads the Vitality Institute, an evidence-driven and action-oriented research organization founded by Discovery Holdings and dedicated to health promotion and the prevention of chronic disease to build a culture of health.
Previously, he served as SVP Global Health and Agriculture Policy at PepsiCo., headed global health at the Rockefeller Foundation, and was a Professor of Global Health at Yale University. Dr. Yach is also a former Executive Director for Noncommunicable Diseases and Mental Health of the World Health Organization (WHO). At WHO, he served as cabinet director under Director-General Gro Harlem Brundtland where he led the development of WHO’s Framework Convention on Tobacco Control and the Global Strategy on Diet and Physical Activity.
Dr. Yach established the Centre for Epidemiological Research at the South African Medical Research Council, has authored or co-authored over 200 articles covering the breadth of global health, and continues to publish regularly on topics including but not limited to tobacco control, e-cigarettes, workplace health, and the importance of cross-sector collaboration for improved population health. He serves on several advisory boards including those of the Clinton Global Initiative, the World Economic Forum and the Wellcome Trust’s Sustaining Health Initiative, and was nominated in September 2014 as the Chair of the World Economic Forum’s Global Agenda Council on Ageing.
His degrees include an MBChB from the University of Cape Town, BSc (Hons Epi) from the University of Stellenbosch and an MPH from the Johns Hopkins Bloomberg School of Public Health.
The Michael Russell Oration has been established as an annual event, delivered to honour the work and memory of Professor Michael Russell, one of the pioneers in the study of smoking behaviour, clinical interventions and public policy action, who died in 2009. The oration will be given by a leading researcher, practitioner or commentator in the field of nicotine use”

Dr. Riccardo Polosa

Dr. Riccardo Polosa

Vaping shops and smoking cessation

Watch Video
Director of the Institute for Internal and Emergency Medicine of the University of Catania in Italy. He is also in charge of the University’s Centre for Tobacco Research (CPCT), and Honorary Professor of Medicine at Southampton University (UK). He is author of more than 250 peer reviewed articles and books mainly covering respiratory medicine, clinical immunology, and tobacco addiction.
On top of his academic work, he serves also as chief scientific advisor for Lega Italiana Anti Fumo (LIAF), the Italian Anti-Smoking League. Prof Polosa’s and his research team have lead several clinical trials on e-cigarettes.

 

Professor Linda Bauld

Professor Linda Bauld

Young people and reduced risk products

Watch Video
Linda Bauld is Professor of Health Policy at the University of Stirling, Director of the Institute for Social Marketing and Deputy Director of the UK Centre for Tobacco and Alcohol Studies. She has a background in applied policy research and for the past 15 years her research interests have centred on the evaluation of public health interventions. She has conducted studies on drug and alcohol use, inequalities in health and, most notably, on tobacco control and smoking cessation. She is a former scientific adviser on tobacco control to the UK government and currently chairs a number of public health advisory and funding committees for NICE, Cancer Research UK and the Scottish government.

Dr. Konstantinos Farsalinos

Dr. Konstantinos Farsalinos

Pitfalls in e-cigarette research: Lessons from the current literature

Watch Video

Second Presentation – From first to fourth generation products and beyond

Watch Video
Dr. Konstantinos Farsalinos is a cardiologist, working as researcher at Onassis Cardiac Surgery Center in Athens-Greece and at Medical Imaging Research Center, University Hospital Gathuisberg in Leuven-Belgium. His main research interests are new modalities in cardiovascular imaging and he has received a scholarship from the Greek Society of Cardiology for research and education in this field. He has studied the effects of smoking on subclinical cardiac dysfunction using new imaging techniques since 2010.

He has been actively performing research on electronic cigarettes since 2011 as a principle investigator, in both clinical and laboratory level. Examples of his work include the first study on the cytotoxic effects of electronic cigarette vapor on cultured cells and the immediate effects of electronic cigarettes used on cardiac function and coronary circulation. He has presented his research in major international scientific congresses and has published more than 15 studies and letters about e-cigarettes in peer-reviewed medical journals.

Clive Bates

Clive Bates

Prohibition or profit motive?

Watch Video
Clive Bates has had varied career having worked in the private sector for IBM, in the UK government in Tony Blair’s Strategy Unit, the United Nations in Sudan, for Greenpeace and for Action on Smoking and Health in the UK, which is why he is interested in smoke free alternatives to tobacco. Since early 2013 he has his own public interest consultancy and advocacy organisation, including the Counterfactual blog. He is interested in the enormous public health potential of tobacco harm reduction and is not engaged by pharmaceutical, e-cigarette or tobacco interests.

Dr. Marewa Glover

Dr. Marewa Glover

E-cigarettes and vaping in New Zealand

Watch Video
Dr. Mareva Glover works at the University of Auckland’s Centre for Tobacco Control Research. Since her award-winning doctoral research on Māori smoking cessation in 2000, she has led and supported many tobacco control and Māori health research projects. Dr. Glover has been trying to help smokers quit the habit for more than 17 years. Her project WERO is a group stop smoking contest that uses iPad and iPhone apps to get teams of people quitting smoking together, and is just one intervention aimed at halving the number of Māori and Pacific smokers by 2020. The project was one of 12 to qualify for the Spark $100K Challenge in 2011. It is based on Māori and Pacific cultural values, focusing on teams rather than individuals, and uses non-smokers or ex-smokers as coaches.

Dr. Atila Danko

Dr. Atila Danko

Australia’s war on vapor; no endgame in sight

Watch Video
Dr. Attila Danko is an experienced, busy General Practitioner in Ballarat, a regional city in Australia. Over the last few years, several of his patients have surprised him by being able to give up smoking using electronic cigarettes when all other methods had failed. Inspired by the potential revolution in smoking cessation this represents, and appalled by the prohibitionist policies of his country, he began to advocate for the liberalisation of laws in Australia that effectively ban nicotine containing electronic cigarettes. He recieves no payment or any inducement whatsoever from any Pharmaceutical, Tobacco or Electronic cigarette company. He is in the preliminary stages of working with Professor Ron Borland, Nigel Gray Distinguished Fellow in Cancer Prevention at Cancer Council Victoria, Australia, on an upcoming study on electronic cigarettes.

Dr. Sally Satel

Dr. Sally Satel

GFN2015, A personal overview

Watch Video
Dr. Sally Satel is a resident scholar at AEI and the staff psychiatrist at a local methadone clinic in D.C. Dr. Satel was an assistant professor of psychiatry at Yale University from 1988 to 1993 and remains a lecturer at Yale. From 1993 to 1994 she was a Robert Wood Johnson policy fellow with the Senate Labor and Human Resources Committee. She has written widely in academic journals on topics in psychiatry and medicine, and has published articles on cultural aspects of medicine and science in numerous magazines and journals. She has testified before Congress on veterans’ issues, mental health policy, drug courts,and health disparities. Dr. Satel is author of Drug Treatment: The Case for Coercion (AEI Press, 1999), and PC, M.D.: How Political Correctness Is Corrupting Medicine (Basic Books, 2001). She is coauthor of One Nation under Therapy (St. Martin’s Press, 2005), co-author of The Health Disparity Myth (AEI Press, 2006), and editor of When Altruism Isn’t Enough: The Case for Compensating Kidney Donors (AEI Press, 2009). Her recent book, co-authored with Emory psychologist Scott Lilienfeld is Brainwashed: The Seductive Appeal of Mindless Neuroscience (Basic, 2013). Brainwashed was a finalist for the 2013 Los Angeles TimesBook Prize in Science.

Christopher Russell, Ph.D.

Christopher Russell, Ph.D.

The potential benefits of even very brief, first time use of an e-cigarette by current smokers

Watch Video
Dr. Russell received his BA Hons (1st Class, Psychology), Masters in Research (With Distinction, Psychology), and PhD. (Psychology) all from the University of Strathclyde.

Christopher’s research interests cover several broad areas of substance misuse treatment and policy. As part of his doctoral research, Christopher compared the relative efficacy of two types of behavioural intervention for smoking cessation – Cognitive-Behavioural Therapy (CBT) and Acceptance and Commitment Therapy (ACT) – delivered to small groups of motivated-to-quit smokers over three, consecutive weekly, two-hour sessions. He also assessed mediation of long-term smoking outcomes by the theoretically-distinct putative mechanisms of action underlying each intervention.

Christopher has published research on theories of addiction, interpretations of scientific evidence supporting the disease and choice models of addiction, governing and motivating factors in addictive behaviour, issues regarding free will and responsibility for behaviour, and legal, clinical and public policy issues regarding public education on the nature of addiction and effectiveness of addiction treatment. With his training background in research methodology and statistical analysis, he has also conducted impact assessments of alcohol treatment services in Scotland and has assisted with the development of psychosocial interventions to discourage smokers from purchasing illicit tobacco products.

Product Standards :
The “Standards” were discussed in two separate segments. Each has three individual speaker presentations followed by a panel discussion with a “First Responder” followed by a “Second Responder” and then all five participants answering audience questions. Below you will see each speaker and the video of their individual presentation followed by a “Panel Discussion” video – all speaker profiles are interlaced:

Part 1 – “Finding Gridlocks – What kind of standards regime is “just right” for the vapour industry: keeping things in perspective”

Alberto Simeoni

Alberto Simeoni

What kind of standards regime is “just right” for the vapour industry: keeping things in perspective”

Watch Video
Alberto Simeoni seeks for new opportunities for standardization in the Innovation Department at CEN-CENELEC, the formally recognised organizations for standardization in Europe. After having served the Italian standards body for 14 years, he supports CEN-CENELEC to attract new stakeholders and identify new ideas and needs that can be addressed by European standards and other deliverables, in coordination with the National standards bodies. Contacts with the e-cigarettes business associations resulted into the proposal to create in January 2015 the new Technical Committee – CEN/TC 437 ‘Electronic cigarettes and e-liquids’.

Katherine Devlin

Katherine Devlin

The British Standard Institute standard for e-cigarettes - PAS 54115

Watch Video
Photo and profile to come…

Yushu Zhu

Yushu Zhu

Standards in China, meeting the challenge of a regulated market

Watch Video
Yushu worked in pharmaceutical Industry for 21 years, which 15 years in China and 6 years in the UK. He has worked with international pharmaceutical and biotechnology companies on custom strategy for drug development and manufacturing. He was a regular speaker in many international pharmaceutical conferences, and he was also a columnist for a leading Chinese pharmaceutical journal. Yushu is UK Chartered Marketer 2004-2015 and he is Member of Charted Institute of Marketing of UK. Yushu is a Chinese Christian.

 

Part 1 – PANEL DISCUSSION (with First & Second Responders): Finding gridlocks

Watch Video

First Responder - Clive Bates

First Responder - Clive Bates

Counterfactual Consulting, United Kingdom

Clive Bates has had varied career having worked in the private sector for IBM, in the UK government in Tony Blair’s Strategy Unit, the United Nations in Sudan, for Greenpeace and for Action on Smoking and Health in the UK, which is why he is interested in smoke free alternatives to tobacco. Since early 2013 he has his own public interest consultancy and advocacy organisation, including the Counterfactual blog. He is interested in the enormous public health potential of tobacco harm reduction and is not engaged by pharmaceutical, e-cigarette or tobacco interests.

Second Responder - Joe Gitchell

Second Responder - Joe Gitchell

PinneyAssociates, USA

Joseph (Joe) G. Gitchell serves as President at PinneyAssociates, with responsibility for client service, and leads the Marketing Strategy team. Mr. Gitchell leads efforts supporting regulatory approvals, conducting public policy analysis, developing marketing approaches, devising, refining and defending claims (including extensive claims challenge support) and providing input on strategic market opportunities and directions. He has worked for clients in the US, Europe, Latin America, Asia and the Middle East. This work has included extensive collaboration with researchers and policy experts around the world.

A co-author on almost 40 articles, Mr. Gitchell has been published in journals including Tobacco Control, Preventive Medicine, Addiction, Archives of Internal Medicine and Morbidity and Mortality Weekly Report.

Part 2 – LESSONS FROM ELSEWHERE – what can the vapour industry learn from other sectors?

Jack Henningfield

Jack Henningfield

OTC medicines in the USA

Watch Video
Jack Henningfield is Vice President, Research, and Health Policy at PinneyAssociates, and Adjunct Professor of Behavioral Biology, in the Department of Psychiatry and Behavioral Sciences at The Johns Hopkins University School of Medicine. He served on FDA’s first Tobacco Products Scientific Advisory Committee (TPSAC) from 2010 to 2011, and the World Health Organization’s first Tobacco Regulation Study Group and its predecessor the Scientific Advisory Committee on Tobacco Regulation from 2000 to 2014. Before PinneyAssociates, he headed the Clinical Pharmacology Branch of the National Institute on Drug Abuse (NIDA) where he regularly advised the FDA on matters concerning abuse and dependence liability of a broad range of drugs and regulatory challenges including tobacco and nicotine products and FDA’s proposed Tobacco Regulation.

David Sweanor, JD

David Sweanor, JD

Lessons from the history of product regulation

Watch Video
Adjunct Professor, Faculty of Law, University of Ottawa
Special Lecturer, Division of Epidemiology and Public Health, University of Nottingham
David Sweanor has been actively involved in tobacco and health policy issues since the beginning of the 1980s. He has worked with numerous companies and organisations, including the International Union Against Cancer, World Health Organization, World Bank and the Pan American Health Organization, and currently focuses much of his efforts on risk reduction strategies. He has received both international recognition and prestigious prizes for his work.

Inger Wahlberg

Inger Wahlberg

Snus and Gothia Tek

Watch Video
Dr. Inger Wahlberg (IWG Consulting, Sweden) received her Ph.D. in chemistry in 1971 and was appointed Associated Professor in organic chemistry in 1974 at the University of Stockholm. She held various positions at the Research Department of Swedish Match for many years and worked as a scientific advisor for Swedish Match until her retirement in 2006. She has published more than 100 peer-reviewed articles in scientific journals covering tobacco chemistry and natural products chemistry in general. Inger Wahlberg is currently a consultant specialized on issues relating to tobacco and public health.

 

Part 2 – PANEL DISCUSSION: Lessons from elsewhere
Watch Video

First Responder - Lou Ritter

First Responder - Lou Ritter

AEMSA/E-Research Foundation, USA

As co-founder, first elected President (now President Emeritus) of the American E-liquid Manufacturing Standards Association (AEMSA), and launch term President of ERF, Lou serves as an unpaid consumer volunteer with no financial involvement in the industry. AEMSA is a nonprofit 501(c)(6) professional trade association establishing the world’s only self-regulation verifying e-liquid manufacturing standards. Representing AEMSA, Lou has presented before the USA FDA five times, met with OMB/OIRA, speaks at industry-leading conferences more. E-Research Foundation (soft launched November 2014) is a nonprofit 501(c)(3) designed to be an industry-wide collective funding portal to advance independent medical/scientific research targeted for peer-review and publication.

Second Responder - Monica Vialpando

Second Responder - Monica Vialpando

Liberty flights, UK

Dr. Monica Vialpando is the Chief Scientific Officer at Liberty Flights, a UK-based e-cigarette company. She received her Ph.D. in Pharmaceutical Sciences from KU Leuven in Belgium. Prior to this role, she worked six years in the pharmaceutical industry for U.S. and European-based companies such as Novartis and Johnson & Johnson. The emphasis of her industrial research was dedicated to formulation strategies for inhalation in both early-to late-stage drug development projects. Given Dr. Vialpando¹s background and on-going engagement within the commercial, academic, regulatory and social fields, she provides a holistic insight into vaping and its impact.

 

© 2014 E-Research Foundation. All Rights Reserved.